Patients die because signs of deterioration are missed. There is a huge unfulfilled need for better monitoring of vital signs to identify high-risk patients who are on general hospital wards or at home. Patient deterioration is often detected too late or not at all. One of the reasons is the decrease in intensity of vital signs monitoring and nurse attendance from the intensive care to the ward and at home. Early detection of vital instability is crucial to prevent death and disability.
Pre-commercial Procurement (PCP)
Nightingale uses the European commission’s Pre-commercial Procurement (PCP) funding scheme to challenge and stimulate European industry to develop a system to connect patients and carers to wirelessly monitor patients’ vital signs and identify high risk individuals. The available budget for the development of this innovative solution is 5.3 million euro, consisting of 3.75 million euro in the form of innovation subsidies to the industry.
Finding a solution
The solution should consist of one or more unobtrusive wireless sensors that do not interfere with the patient’s daily activities or rehabilitation. Intelligent analysis software is a key feature of the requested system, as the false alarm rate must be extremely low to be acceptable to the users. It should be well-integrated into the hospital’s electronic medical record system. The sensors should involve a mechanism that allows patients and informal carers to communicate with their healthcare team, and allow entry of qualitative data (e.g., pain and well-being scores).
Interested parties should familiarise themselves with the Nightingale Common Challenge document and complete an interested parties questionnaire. Check the website for more information: http://www.nightingale-h2020.eu/